Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
The Classical Pathway test evaluates how well the classical arm of your complement system is working. The complement system is a network of proteins in your blood that helps your immune system recognize and clear microbes and immune complexes. This assay looks at the overall, real-world performance of the classical pathway proteins acting together to form the membrane attack complex and mediate immune defense.
Clinicians often order this test together with other complement measurements, such as C3, C4, and an alternative pathway assay, to understand where a problem might lie and whether complement is being overused, underproduced, or blocked.
Your clinician may order this test if you have repeated bacterial infections, signs of an immune system problem, certain autoimmune conditions, or unexplained inflammation. It helps detect inherited deficiencies of complement proteins and acquired issues where complement is being consumed by active disease. It can also help monitor disorders that activate complement and assess the effect of medicines that intentionally block complement activity.
Results can guide next steps such as vaccines, infection prevention strategies, and referrals to immunology or rheumatology. Understanding classical pathway function can also help tailor therapy and track response over time.
Results are interpreted in the context of your symptoms and other lab tests. Lower-than-expected activity can suggest a hereditary lack of one or more classical pathway proteins, ongoing consumption during active autoimmune disease or infection, or reduced production in significant liver disease. Higher-than-expected activity can be seen with inflammation or during pregnancy; your care team will consider the clinical setting.
If results are unexpected, your clinician may repeat the test after any acute illness resolves, review medications that affect complement, or order targeted follow-up such as individual complement components or genetic testing. Do not change medicines without medical advice; discuss questions and next steps with your clinician.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Complement proteins are fragile. Delayed processing, heat inactivation, or improper storage can falsely lower measured activity. Prompt separation and proper transport are important.
Active infections and autoimmune diseases can consume complement, leading to temporarily reduced classical pathway activity during a flare.
Drugs such as eculizumab and other complement inhibitors lower classical pathway activity by design. Recent biologic or immunosuppressive therapies may also influence results.
Most complement proteins are made in the liver. Significant liver disease can reduce production and lower functional activity.
Complement proteins can be increased during pregnancy or with estrogen-containing therapies, which may raise measured activity.
This assay typically requires serum. EDTA and some other anticoagulants chelate ions needed for complement activation and can artifactually lower activity.
Newborns may have lower complement activity, and inherited complement deficiencies can produce persistently low classical pathway function.
Blood products may transiently change complement levels, which can complicate interpretation shortly after transfusion.
References